Matrix metalloprotease-3 and -9 proteolyze insulin-like growth factor-binding protein-1

Biology of Reproduction

Volumn 71, Issue 2, 2004, Pages 438-443

  Coppock, Hedley A ^a   White, Anne ^a   Aplin, John D ^a   Westwood, Melissa ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Decidua; Growth factors; Placenta; Trophoblast

Indexed keywords

ALPHA 2 MACROGLOBULIN; GELATINASE B; PROTEINASE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DECIDUA; ENZYME MECHANISM; ENZYME SYNTHESIS; FEMALE; FETUS DEVELOPMENT; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; MOTHER FETUS RELATIONSHIP; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; TROPHOBLAST; WESTERN BLOTTING;

AMINO ACID SEQUENCE; CELL MOVEMENT; DECIDUA; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MOLECULAR SEQUENCE DATA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TROPHOBLASTS;

EID: 3242752043     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.103.023101     Document Type: Article

References (47)

1. Blair E, Stanley F. Intrauterine growth and spastic cerebral palsy. I. Association with birth weight for gestational age. Am J Obstet Gynecol 1990; 162:229-237.
2. Barker DJ, Gluckman PD, Godfey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341:938-941.
3. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (noninsulin-dependent)diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36:62-67.
4. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993; 75:59-72.
5. Baker J, Liu J-P, Robertson E, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75:73-82.
6. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley CP, Reik W. Placental-specific IGF2 is a major modulator of placental and fetal growth. Nat Med 2002; 417:945-948.
7. Han VK, Bassett N, Walton J, Challis JR. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the fetomaternal interface. J Clin Endocrinol Metab 1996; 81:2680-2693.
8. Lacey H, Haigh T, Jones CJ, Westwood M, Aplin JD. Mesenchymally derived IGF-I provides a paracrine stimulus for trophoblast migration. BMC Dev Biol 2002;2:5.
9. Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGFβ, IGF-II, and IGFBP-1. Exp Cell Res 1995; 217:419-427.
10. Hamilton GS, Lysiak JJ, Han VK, Lala PK. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res 1998; 244:147-156.
11. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16:3-34.
12. Koistinen R, Kalkinnen N, Huhtala ML, Seppala M, Bohn H, Rutanen E-M. Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology 1986; 118:1375-1378.
13. Bell SC, Patel S, Jackson JA, Waites GT. Major secretory protein of human decidualized endometrium in pregnancy is an insulin-like growth factor-binding protein. J Endocrinol 1988; 118:317-328.
14. 1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. Growth Horm IGF Res 1998; 8:21-31.
15. Gibson JM, Aplin JD, White A, Westwood M. Regulation of insulin-like growth factor bioavailability in pregnancy. Mol Hum Reprod 2001; 7:79-87.
16. Salamonsen LA, Zhang J, Hampton A, Lathbury L. Regulation of matrix metalloproteinases in human endometrium. Hum Reprod 2000; 15:112-119.
17. Aplin JD. Endometrial extracellular matrix. In: Glasser SR, Aplin JD, Giudice LC, Tabibzadeh S (eds.), The Endometrium. London: Taylor & Francis; 2002:294-307.
18. Aplin JD. Implantation, trophoblast differentiation and hemochorial placentation: mechanistic evidence in vivo and in vitro. J Cell Sci 1991; 99:668-692.
19. Campbell S, Rowe J, Jackson CJ, Gallery ED. In vitro migration of cytotrophoblasts through a decidual endothelial monolayer: the role of matrix metalloproteinases. Placenta 2003; 24:306-315.
20. Fisher SJ, Damsky CH. Human cytotrophoblast invasion. Semin Cell Biol 1993; 4:183-188.
21. Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the development puzzle. Science 1994; 266:1508-1517.
22. Vicovac LM, Starkey PM, Aplin JD. Comment: effect of cytokines on prolactin production by human decidual stromal cells in culture: studies using cells freed of bone marrow-derived contaminants. J Clin Endocrinol Metab 1994; 79:1877-1882.
23. Vettraino IM, Roby J, Tolley T, Parks WC. Collagenase-I, stromelysin-I, and matrilysin are expressed within the placenta during multiple stages of human pregnancy. Placenta 1996; 17:557-563.
24. 2-Macroglobulin: A new component in the insulin-like growth factor/ insulin-like growth factor binding protein-1 axis. J Biol Chem 2001; 276:41668-41674.
25. Fowlkes JL, Thrailkill KM, Serra DM, Suzuki K, Nagase H. Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res 1995; 6:255-263.
26. Manes S, Mira E, Barbacid MM, Cipres A, Fernandez RP, Buesa JM, Merida I, Aracil M, Marquez G, Martinez AC. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 1997; 272:25706-25712.
27. Shi Z, Xu W, Loechel F, Wewer UM, Murphy LJ. ADAM-12, a disintegrin metalloprotease, interacts with insulin-like growth factor binding protein-3. J Biol Chem 2000; 275:18574-18580.
28. Irwin JC, Suen L-F, Cheng B-H, Martin R, Cannon P, Deal CL, Giudice LC. Human placental trophoblast secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serum. Endocrinology 2000; 141:666-674.
29. 2-Macroglobulin controls trophoblast positioning in mouse implantation sites. Placenta 2003; 24:912-921.
30. Maile LA, Holly JM. Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm IGF Res 1999; 9:85-95.
31. Crossey PA, Pillai CC, Miell JP. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest 2002; 110:411-418.
32. 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci U S A 1993; 90:10553-10557.
33. 1 integrin via mitogen activated protein kinase pathway. J Clin Endocrinol Metab 2001; 86:2484-2493.
34. 3 by low antagonist concentrations. J Cell Sci 2001; 114:1545-1553.
35. Houseman BT, Mrksich M. The microenvironment of immobilized Arg-Gly-Asp peptides is an important determinant of cell adhesion. Biomaterials 2001; 22:943-955.
36. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ. Integrin switching regulates normal trophoblast invasion. Development 1994; 120:3657-3666.
37. 1. Biol Reprod 1999; 60:828-838.
38. Alexander CM, Hansell EJ, Behrendtsen O, Flannery ML, Kishnani NS, Hawkes SP, Werb Z. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996; 122:1723-1736.
39. Hurst PR, Palmay RD. Matrix metalloproteinases and their endogenous inhibitors during the implantation period in the rat uterus. Reprod Fertil Dev 1999; 11:395-402.
40. Skinner JL, Riley SC, Gebbie AE, Galsier AF, Critchley HO. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum Reprod 1999; 14:793-799.
41. Huppertz B, Kertschanska S, Demir AY, Frank HG, Kaufmann P. Immunohistochemistry of matrix metalloproteinases (MMP), their substrates and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res 1998; 291:133-148.
42. Sawicki G, Radomski MW, Winkler-Lowen B, Krzymien A, Guilbert LJ. Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Biol Reprod 2000; 63: 1390-1395.
43. Bischof P, Meisser A, Campana A, Tseng L. Effects of decidua-conditioned medium and insulin-like growth factor-binding protein-I on trophoblastic matrix metalloproteinases and their inhibitors. Placenta 1998; 19:457-464.
44. Bischof P. Paracrine and autocrine regulators of trophoblast invasion-a review. Placenta 2000; 21:S55-S60.
45. Marzusch K, Ruck P, Dietl JA, Horny HP, Kaiserling E. Immunohistochemical localization of tissue inhibitor of metalloproteinases-2 (TIMP-2) in first trimester human placental decidua. Eur J Obstet Gynecol Reprod Biol 1996; 68:105-107.
46. Qin X, Chua PK, Ohira RH, Bryant-Greenwood GD. An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). Biol Reprod 1997; 56:812-820.
47. Fortunato SJ, Menon R, Lombardi SJ. Presence of four tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -3, and -4) in human fetal membranes. Am J Reprod Immunol 1998; 40:395-400.